Abstract -Despite impressive advances in techniques for sequence analysis of nucleic acids, direct sequencing of proteins will continue tobe reqliired in many areas of biological research.
INTRODUCTION
Only a few years ago the determinaöon of amino acid sequences of polypepödes represented the only practical approach to problems requiring decoding of genetically regulated informational macromolecules. Thus sequence analyses of numerous globins, cytochrome C molecules, immunoglobulins, pepöde hormones and enzymes provided insight into a variety of geneöc and cellular regulating systems as well as indicating the main lines of molecular evolution. At that time techniques for sequencing DNA were primitive, so that mutations in the germ cellline had tobe inferred from alterations found in the polypeptide products of the genes under study. Degeneracy in the genetic code necessarily introduces a minor element of uncertainty into this kind of analysis since at least some mutational events would not, in fact, result in a different polypeptide. With the advent of modern techniques for DNA sequencing, reviewed by Sanger at this meeting (Ref. 1) the tables have almost been turned, and in some situations it may now prove easier to sequence the gene rather than its polypepöde product. However, there is little doubt that, these advances in nucleic acid chemistry notwithstanding, direct microsequencing of biologically active proteins and peptides will continue to be required on a major scale for a long time to come.
Successive editions of the "Atlas of Protein Sequences "edited by Margaret 0. Dayhoff (Ref. 2) attest to the rapid growth in our knowledge of protein structure. Almostall the proteins studied to date, however, have been those quite readily purified in relatively abundant quantities (tens or hundreds of micromoles). Thus tradiöonal sequencing procedures developed in the 1950's and 1960's have been applied. However, a whole series of new problems now require much more sensitive sequencing techniques, in conjuncöon with scaled-down isolation procedures~ The current interest in the structure and properties of the membrane-bound proteins found at cell surfaces is to a great extent responsible for this. Anumber of other polypeptides with hormonal or regulatory properties can only be isolated in trace quanööes.
A simple example gives some idea of the magnitude of the problem. Cell surface receptors for drugs and for pepöde hormones represent a class of protein of great physiological interest and potential therapeutic importance. We know almost nothing of their chemistry other than that they are of high molecular weight (at least 150, 000 daltons), may consist of subunits, and probably have a carbohydrate component. Kinetic experiments using radioactively labelled hormones reveal that these are of the order of only a few thousand hormone receptor molecules per cell (Ref. 3) . Receptor protein represents 1 part by weight in 107 of the total membrane protein. Thus a ten millionfold purification is required. Tsushima and coworkers (Ref. 4) report an overall yield of the growth hormone receptor isolated from pregnant rabbit liver of about 2 nanograms per 100 gms of tissue -i. e. femtomole (lQ-15 moles) amounts. · Clearly extremely sensitive sequencing techniques of a kindnot yet developed will be required to cope with this and similar problems.
APPROACHES TO lVIICROSEQUENCE ANALYSIS
Mass spectrometry Initiäl studies were carried out in 1958 by Anderson (Ref. 5 ) who first used mass spectrometry for the analysis of small peptides after trüluoroacetylation and esterification to render them volatile. Stenhagen (Ref. 6 ) has suggested a similar approach. Even less polar and more volatile derivatives were prepared by Biemann and coworkers (Ref. 7) who reduced the carbonyl groups of the peptidebackhone to the corresponding polyaminoalcohols. Das et al (Ref. 8 ) used a permethylation technique. All of these manoeuvers are directed towards rendering non-polar the many polar functional groups of peptides, since these restriet volatility. This problern limits the direct application of mass spectrometry in microsequencing, since, even with derivatization, peptides bigger than 15 -20 residues usually cannot be anq.lysed. The need for derivatization also Introduces handling losses and restricts the sensitivity of the approach. A further problern is that peptides isolated from biological sources are often contaminated by trace amounts of products derived from Chromatographie media. These introduce spurious peaks into the mass spectrometry analysis. For all these reasons mass spectrometry , despite almost two decades of effort by expert groups, has never really become established as a useful practical technique for peptide sequencing. Notable exceptions include the elegant analysis of gastrin by Kenner (Ref. 9 ) and of the hypothalamic hormone releasing peptides LHRH and TRH.
A recent approach of promise combines enzymatic and chemical methods with mass spectrometry (Refs. 10, 11) as summarized in Table 1 . Peptides are reduced to 2 sets of dipeptides representing all possible dipeptide combinations which can be generated from the parent peptide. Initially arginyl and prolyl residues gave trouble as they may be resistant to the aminodipeptidases used. However, newer enzymes have now been found which can split bonds involving these residues. Ambiguities obviously can arise where there are repeating sequences, and often additional experiments must be done. Nevertheless, Krutzsch and Pisano (Ref. 11) have convincingly demonstrated the practicality of the technique at the level of a few nanomoles, on a variety of shorter peptides. Sequence analysis by mass spectrometry
Treat with aminodipeptidase set of dipeptides (AB, CD, etc)
Remove terminal amino acid by Edman degradation ---BCDEFGHIJKLMNOP
Generate second set of dipeptides with aminodipeptidase (BC, DE, etc) 3. Derivatize each set of dipeptides (polyaminoalcohols, trimethylsilylation)
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Clearly at present mass spectrometry represents at best a partial answer to the problern of microsequencing, since only relatively short peptides can be handled and one does not escape the need for protein fragmentation and isolation. Thus the technique remains expensive in time, labour and, not least importa.nt, the cost of the sophisticated equipment required. In the long term, however, it may prove the method of choice, since it has the potential of analysing at high sensitivity complex peptide mixtures without necessarily isolating individual peptides. It is already the best way of analysing smaller peptides with unusual structural features (e. g. cyclic peptides, those containing D-amino acids) which resist standard chemical or enzymatic techniques.
COMPOSITIONAL APPROACH
Insulin was originally sequenced in Sanger 's classical work (Ref. 12 ) by a process of generating a large number of different, overlapping peptide Subfragments using düferent cleavage procedures. From the amino acid composition of these fragments and from end group analyses (by the DNP method) the structure could be put together. The development of a good sequential chemical method by Edman (Ref. 13 ) soon rendered the compositional method obsolete. However, it is worth remembering that techniques for end group analysis by the 14c dansyl, 35S phen~lisothiocyanate or sulphoindonyl techniques (Refs. 14-16) now require only picomole (1o-1 M) quantities. Amino acid composition of peptides can also be obtained at the picomole Ievel using the double isotope dansyl chloride technique (Ref. 14~ Thus the sensitivity of this "old-fashioned " sequencing approach is now limited only by the ability to isolate peptides at the picomole Ievel. Thin layer mapping of 14c dansylated peptide digests represents one possible avenue which is currently being explored in our Iabaratory.
SEQUENTIAL APPROACH
Sequential methods depend upon the application of a repetitive process which splits amino acids one by one from the N or C terminal end of a peptide chain. The amino acids are then identified either as such or as chemical derivatives. Obviously this approach fails in the special case of cyclic peptides like valinomycin and when the terminal residue has an atta.ched Substituent block:i.ng the degradation ( e. g. N terminal acetyl, formyl or pyrogluta.myl groups ; C terminal amide). The repetitive process can be chemical or enzymatic, but in practice the sequential enzymatic approach is limited. This is because ·the process of amino acid release by amino-or carboxy-peptidases is continuous, and the order of release is soon obscured as düferent molecules are digested at differing rates.
Chemical degradations are available for both N-and C-terminal approaches. Of these the N -terminal method devised by Edman (Ref. 13 ) is by far the most successful. In fact it has dominated sequencing methodology for at least 20 years and there is so far no sign that ü will be soon supplanted.
Edman degradation
The chemistry of this technique is now in every sta.ndard text book. However, it must be reviewed briefly here in the context of high sensitivity sequencing.. The reagent phenylisothiocyanate reacts with the N-terminal a amino group of the peptide chain to give a phenylthiocarbamyl adduct. Under anhydrous acidic conditions (e. g. trüluoroacetic acid) the proximity of the sulfur atom to the carbonyl component of the first peptide bond allows the ready formation of a heterocyclic derivative of the first amino acid in the chain, with concomitant cleavage of the bond link:ing it to the next residue. The derivative formed is an anilinothiazolinone. This is extracted away from the residualpeptidein an organic solvent. It is then exposed separately to aqueous acidic conditions (1N HCI, 10 minutes, 8QOC) when it rearranges .. to. form a more stable derivative, a phenylthiohydantoin (PTH), which is then identified by a Chromatographie procedure. The shortened peptide can then be subjected to repetitions of this procedure, with successive removal of the second, third and subsequent derivatives as PTH amino acids. The coupling and cleavage steps under appropriate conditions proceed almost quantitatively, and the technique has been successfully automated (Ref.14 ) . Degradations of up to 50 -60 cycles are possible on suitable proteins in the automated instrument, termed a "sequenator". Provided enough material is available shorter peptides (up to 30 amino acids) can usually be sequenced completely by this procedure. Clearly if sensitivity of analysis is not a problem, entire proteins can be (and have been) sequenced virtually by this procedure alone, granting that some Subfragments will still have to be isolated.
Since here our focus is on microsequencing, Iet us consider Ule limitations of the Edman procedure when only trace amounts (say 1 nM) of peptide are available (Table 2) . Some imperfections in the degradation (e. g. incomplete coupling or cleavage) tend to occur regardless of the amount of material. Though they Iimit the length of a degradation, there is no special difficulty when nanomole quantities are being sequenced. Non-specific peptide bond cleavage is in the same category. However, certain side-reactions become particularly important as the quantity of peptide decreases. Competing reactions such as aminoterminal blocking or desulfuration of the phenylthiocarbamyl adduct are due to finite quantities of impurities including oxidants in the reagents and solvents used. In addition there aresmall mechanicallosses of polypeptide during the solvent extraction steps. Finally, if the yield of PTH amino acids obtained is too low, there is insufficient for identification. Over the past several years my colleagues and I have developed several approaches which used together overcome these problems, at least to the extent of allowing useful sequence information to be obtained on subnanomole amounts of material. Degradations are carried out in the presence of a poly-amino acid carrier, ideally composed of non-natural amino acids. A copolymer of norleucine and argininewas used for initial evaluation of this approach (Ref.18) . Polyhydroxyproline was also found tobe a suitable carrier for degradation of proteins· excepting, of course, those derived from collagen. Silver and Hood (Ref. 19) have independently used a similar technique. This approach, which we have termed ''protected Edman degradation 11 , relies upon the mass of carrier polypeptide absorbing the impurities and oxidants referred to above, and thus preventing N-terminal blocking of the peptide. The carrier PTH amino acids protect the "unknown 11 derivatives during handling prior to identification. This is an advantage over the blocked carriers proposed by Silver and Hood, siiice these cannot themselves be degraded. The increased mass of material in the sequenator cup eliminates any important Iosses due to mechanical washout.
The Iimitation imposed bSl the sensitivity of the identification procedure is readily overcome through the use of 5s-phenylisothiocyanate in the degradation (Ref. 20) . The derivatives are identified after two-dimensional thin-layer chromatography. The Iabelied PTH amino acids are located by autoradiography, eluted; and quantitated by scintillation counting.
Some dozens of polypeptides have been sequenced using a combination of the carrier and radioisotope methods, in amounts ranging from 0. 8 to 5 nanomoles. Since there is room for improvement in both the nature of the carrier and in the specific activity of the isotope, further increases in sensitivity should be obtainable.
An alternate approach is feasible when the prote~.rr be sequenced can .be obta.ined in vitro through biosynthesis. Radioactive amino acids ( C and/or 3H) can be incorporated using tissue slice or cell culture techniques or even in-cell-free systems. The protein must then be isolated free of other radiolabelled proteins. This is easier ü the protein under study is the major biosynthetic product of the system. At times one can achieve this by appropriate manipulation of the conditions. For example parathyroid hormone is secreted under the stimulus of a falling or low calcium Ievel. Thus parathyroid tissue slices incubated in a low calciummedium made parathyroid hormonein large amounts, thus facilitating the isolation of radiolabelled hormone. Standardisolation techniques (gel filtration,ion exchange chromatography, disc gel electrophoresis) may be adequate, but it is often advantageaus to use an immunoprecipitation step employing an antiserum specüic for the protein under study.
When the protein is isolated free of other radioactive components, it is mixed with a carrier (virtually any non-radioactive protein will do) and sequenced using automated Edman degradation. In our own studies reported previously (Ref. 20 ) the biosynthetic precursors to parathyroid hormone were isolated and sequenced. Oae of these precursors, termed ''preproparathyroid hormone '', has only a transient existence in the cell of origin, as it is rapidly cleaved enzymatically. However, much of the sequence has now been completed, using material synthesised in a wheat germ system stimulated by parathyroid hormone-specüic messenger RNA. Many laboratories are now using similar approaches for sequencing precursors to other secreted proteins (e. g. peptide hormones, albumin, immunoglobulins). Cell surface proteins such as transplantation antigens are also starting to yield structural information through this microsequencing approach.
The biosynthetic approach to sequence analysis is extremely sensitive, since under favourable circumstances sequences can be obtained on a picomole or less of material.
Unsolved problems.
The above microsequencing approaches based on the sequential Edman degradation are useful and quite sensitive even at their present sta.ge of development. However, there is considerable room for improvement. A good method for extrinsic labelling of polypeptides is desirable when the biosynthetic approach is not applicable. One would like tobe able to Iabel all residues in the chain unüormly and to high specüic activity. A promising technique which still needs further work isthat of Hembree et al (Ref. 21 ) . Proteinsare Iabelied through tritium exchange by microwave activation in the presence of tritium gas in a specially constructed apparatus. Though labelling is not uniform; quite high specüic activities have been obtained.
There is also need for a sensitive sequential method of degradation of peptides from the C terminal end. Renewed interest in this approach was recently shown at a specialist meeting (Refs.22 and 23 ) .
Finally, none of the methods discussed sofarare satisfactory when the peptide chain being degraded is short -in practice less than 20-30 residues. This is because the solvent extractions necessary in sequential degradation Iead to heavy Iosses of peptide. A great deal of work has been devoted to attempts to circumvent this problern by coupling the peptide to be degraded to a solid support (for a review, see Ref. 24 ) . A related approach,which has great attraction, would be to link the peptide to a soluble polymer, thus making it protein-like in its solvent partition properties.
It is also important to emphasize that when biologically active polypepödes are being studied, a major Iimitation lies in the isolation and bioassay methods. Clearly the bioassay has tobe used to monitor the fractionation steps. lf it requires limiting amounts of matßrial, then progress will be greatly impeded. Here sensitive methods for bioassay that use the amplification provided by enzymatic processes may be weil worth developing, in conjunction with efficient purification by affinity chromatography.
